3.0
Jun 2, 2022
Current employee, more than 3 years
Recommend
CEO approval
Business Outlook
Pros
Great R&D sites and facilities, passionate people, many carreer opportunities
Cons
Style over substance, no clear direction or long-term vision, leadership has huge ambitions but does not create an environment where real innovation can happen. The "Cool Science" strategy and terrible "new modalities" pipeline encourages scientists to focus on their publication records instead of bringing new medicines to the clinic